
CVS Health’s nearly US$70 billion acquisition of health insurer Aetna was given final approval by a Federal judge after a condition set by the Justice Department was achieved.
The merger was allowed on condition Aetna sell its Medicare prescription drug plan business to WellCare Health Plans and both deals have already closed.
US District Judge Richard Leon had questioned whether the settlement did enough to protect competition and consumers in health-care markets.
Judge Leon said on Wednesday, September 4, that the health care markets at issue in the case “are not only very competitive today, but are likely to remain so post-merger.” The settlement “is well within the reaches of the public interest,” the judge concluded, according to Dow Jones.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Crypto Exchange Kraken Buys NinjaTrader for $1.5 Billion
Mar 20, 2025 by
CPI
Airbnb Caught in Contradiction Over EU’s Digital Markets Act
Mar 20, 2025 by
CPI
Atkore Faces Shareholder Lawsuit Over Alleged Price-Fixing Scheme
Mar 19, 2025 by
CPI
US Appeals Court Upholds Ruling Denying Copyright for AI-Generated Art
Mar 19, 2025 by
CPI
Morrison Foerster Expands European Antitrust Practice
Mar 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Self-Preferencing
Feb 26, 2025 by
CPI
Platform Self-Preferencing: Focusing the Policy Debate
Feb 26, 2025 by
Michael Katz
Weaponized Opacity: Self-Preferencing in Digital Audience Measurement
Feb 26, 2025 by
Thomas Hoppner & Philipp Westerhoff
Self-Preferencing: An Economic Literature-Based Assessment Advocating a Case-By-Case Approach and Compliance Requirements
Feb 26, 2025 by
Patrice Bougette & Frederic Marty
Self-Preferencing in Adjacent Markets
Feb 26, 2025 by
Muxin Li